Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2013, Article ID 325086, 7 pages
http://dx.doi.org/10.1155/2013/325086
Research Article

Merkel Cell Carcinoma of the Head and Neck: A Single Institutional Experience

1Division of Otolaryngology, Head and Neck Surgery, University Hospital Zurich, Frauenklinikstraße 24, 8091 Zurich, Switzerland
2Institute of Surgical Pathology, University Hospital Zurich, Frauenklinikstraße 24, 8091 Zurich, Switzerland
3Division of Dermatology, University Hospital Zurich, Frauenklinikstraße 24, 8091 Zurich, Switzerland

Received 28 October 2012; Accepted 22 December 2012

Academic Editor: Boban M. Erovic

Copyright © 2013 G. Morand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Merkel, “Tastzellen und Tastkörperchen bei den Hausthieren und beim Menschen,” Archiv für Mikroskopische Anatomie, vol. 11, no. 1, pp. 636–652, 1875. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Toker, “Trabecular carcinoma of the skin,” Archives of Dermatology, vol. 105, no. 1, pp. 107–110, 1972. View at Publisher · View at Google Scholar · View at Scopus
  3. C. K. Tang and C. Toker, “Trabecular carcinoma of the skin. An ultrastructural study,” Cancer, vol. 42, no. 5, pp. 2311–2321, 1978. View at Google Scholar · View at Scopus
  4. H. Feng, M. Shuda, Y. Chang, and P. S. Moore, “Clonal integration of a polyomavirus in human Merkel cell carcinoma,” Science, vol. 319, no. 5866, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Houben, J. Grimm, C. Willmes et al., “Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis,” The Journal of Investigative Dermatology, vol. 132, no. 1, pp. 254–256, 2012. View at Publisher · View at Google Scholar
  6. X. Sastre-Garau, M. Peter, M. F. Avril et al., “Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis,” Journal of Pathology, vol. 218, no. 1, pp. 48–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. M. Garneski, A. H. Warcola, Q. Feng, N. B. Kiviat, J. H. Leonard, and P. Nghiem, “Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors,” The Journal of Investigative Dermatology, vol. 129, no. 1, pp. 246–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Sihto, H. Kukko, V. Koljonen, R. Sankila, T. Böhling, and H. Joensuu, “Clinical factors associated with merkel cell polyomavirus infection in merkel cell carcinoma,” Journal of the National Cancer Institute, vol. 101, no. 13, pp. 938–945, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. L. Tolstov, D. V. Pastrana, H. Feng et al., “Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays,” International Journal of Cancer, vol. 125, no. 6, pp. 1250–1256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Becker, R. Houben, S. Ugurel, U. Trefzer, C. Pföhler, and D. Schrama, “MC polyomavirus is frequently present in Merkel cell carcinoma of European patients,” The Journal of Investigative Dermatology, vol. 129, no. 1, pp. 248–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Mangana, P. Dziunycz, K. Kerl et al., “Prevalence of Merkel cell polyomavirus among Swiss Merkel cell carcinoma patients,” Dermatology, vol. 221, no. 2, pp. 184–188, 2010. View at Publisher · View at Google Scholar
  12. D. Schrama, W. K. Peitsch, M. Zapatka et al., “Merkel cell polyomavirus status is not associated with clinical course of merkel cell carcinoma,” Journal of Investigative Dermatology, vol. 131, no. 8, pp. 1631–1638, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Higaki-Mori, S. Kuwamoto, T. Iwasaki et al., “Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma,” Human Pathology, vol. 43, no. 12, pp. 2282–2291, 2012. View at Publisher · View at Google Scholar
  14. H. Sihto, H. Kukko, V. Koljonen et al., “Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma,” Clinical Cancer Research, vol. 17, no. 14, pp. 4806–4813, 2011. View at Publisher · View at Google Scholar
  15. C. Andres, U. Puchta, and M. J. Flaig, “Detection of merkel cell polyomavirus DNA in atypical fibroxanthoma in correlation to clinical features,” American Journal of Dermatopathology, vol. 32, no. 8, pp. 799–803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Bobos, P. Hytiroglou, I. Kostopoulos, G. Karkavelas, and C. S. Papadimitriou, “Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung,” American Journal of Dermatopathology, vol. 28, no. 2, pp. 99–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. V. A. Smith, E. R. Camp, and E. J. Lentsch, “Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data,” The Laryngoscope, vol. 122, no. 6, pp. 1283–1290, 2012. View at Publisher · View at Google Scholar
  18. N. C. Hodgson, “Merkel cell carcinoma: changing incidence trends,” Journal of Surgical Oncology, vol. 89, no. 1, pp. 1–4, 2005. View at Publisher · View at Google Scholar
  19. B. A. Reichgelt and O. Visser, “Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007,” European Journal of Cancer, vol. 47, no. 4, pp. 579–585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. Buell, J. Trofe, M. J. Hanaway et al., “Immunosuppression and merkel cell cancer,” Transplantation Proceedings, vol. 34, no. 5, pp. 1780–1781, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Wieland, S. Silling, N. Scola et al., “Merkel cell polyomavirus infection in HIV-positive men,” Archives of Dermatology, vol. 147, no. 4, pp. 401–406, 2011. View at Publisher · View at Google Scholar
  22. J. Kaae, A. V. Hansen, R. J. Biggar et al., “Merkel cell carcinoma: incidence, mortality, and risk of other cancers,” Journal of the National Cancer Institute, vol. 102, no. 11, pp. 793–801, 2010. View at Publisher · View at Google Scholar
  23. R. W. Miller and C. S. Rabkin, “Merkel cell carcinoma and melanoma: etiological similarities and differences,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 2, pp. 153–158, 1999. View at Google Scholar · View at Scopus
  24. M. Van Gele, M. Kaghad, J. H. Leonard et al., “Mutation analysis of P73 and TP53 in Merkel cell carcinoma,” British Journal of Cancer, vol. 82, no. 4, pp. 823–826, 2000. View at Publisher · View at Google Scholar
  25. M. Waltari, H. Sihto, H. Kukko et al., “Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma,” International Journal of Cancer, vol. 129, no. 3, pp. 619–628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. D. Lemos, B. E. Storer, J. G. Iyer et al., “Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system,” Journal of the American Academy of Dermatology, vol. 63, no. 5, pp. 751–761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. M. Balch, D. L. Morton, J. E. Gershenwald et al., “Sentinel node biopsy and standard of care for melanoma,” Journal of the American Academy of Dermatology, vol. 60, no. 5, pp. 872–875, 2009. View at Publisher · View at Google Scholar
  28. O. Boccara, C. Girard, L. Mortier et al., “Guidelines for the diagnosis and treatment of Merkel cell carcinoma—Cutaneous Oncology Group of the French Society of Dermatology,” European Journal of Dermatology, vol. 22, no. 3, pp. 375–379, 2012. View at Publisher · View at Google Scholar
  29. J. L. Schwartz, K. A. Griffith, L. Lowe et al., “Features predicting sentinel lymph node positivity in Merkel cell carcinoma,” Journal of Clinical Oncology, vol. 29, no. 8, pp. 1036–1041, 2011. View at Publisher · View at Google Scholar
  30. S. Asioli, A. Righi, D. de Biase et al., “Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas,” Modern Pathology, vol. 24, no. 11, pp. 1451–1461, 2011. View at Publisher · View at Google Scholar
  31. J. B. Stokes, K. S. Graw, L. T. Dengel et al., “Patients with Merkel cell carcinoma tumors ≤ 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis,” Journal of Clinical Oncology, vol. 27, no. 23, pp. 3772–3777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. A. Sarnaik, J. S. Zager, L. E. Cox, T. M. Ochoa, J. L. Messina, and V. K. Sondak, “Routine omission of sentinel lymph node biopsy for merkel cell carcinoma ≤ 1 cm is not justified,” Journal of Clinical Oncology, vol. 28, no. 1, article e7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Murer, G. F. Huber, S. R. Haile et al., “Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma,” Head & Neck, vol. 33, no. 9, pp. 1260–1264, 2011. View at Publisher · View at Google Scholar
  34. C. S. Landry, K. M. McMasters, and C. R. Scoggins, “The evolution of the management of regional lymph nodes in melanoma,” Journal of Surgical Oncology, vol. 96, no. 4, pp. 316–321, 2007. View at Publisher · View at Google Scholar
  35. R. C. Fields, K. J. Busam, J. F. Chou et al., “Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution,” Annals of Surgical Oncology, vol. 18, no. 9, pp. 2529–2537, 2011. View at Publisher · View at Google Scholar
  36. S. G. Gupta, L. C. Wang, P. F. Peñas, M. Gellenthin, S. J. Lee, and P. Nghiem, “Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma. The Dana-Farber experience and meta-analysis of the literature,” Archives of Dermatology, vol. 142, no. 6, pp. 685–690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Koljonen, T. Böhling, and S. Virolainen, “Tumor burden of sentinel lymph node metastasis in Merkel cell carcinoma,” Journal of Cutaneous Pathology, vol. 38, no. 6, pp. 508–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Howle and M. Veness, “Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience,” The Australasian Journal of Dermatology, vol. 53, no. 1, pp. 26–31, 2012. View at Publisher · View at Google Scholar
  39. S. Miller, NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Merkel Cell Carcinoma, 10th edition, 2012.
  40. K. G. Lewis, M. A. Weinstock, A. L. Weaver, and C. C. Otley, “Adjuvant local irradiation for Merkel cell carcinoma,” Archives of Dermatology, vol. 142, no. 6, pp. 693–700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Jouary, C. Leyral, B. Dreno et al., “Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study,” Annals of Oncology, vol. 23, no. 4, pp. 1074–1080, 2012. View at Publisher · View at Google Scholar
  42. M. Veness, M. Foote, V. Gebski, and M. Poulsen, “The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the australian experience of 43 patients,” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 3, pp. 703–709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Pape, N. Rezvoy, N. Penel et al., “Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients,” Journal of the American Academy of Dermatology, vol. 65, no. 5, pp. 983–990, 2011. View at Publisher · View at Google Scholar
  44. C. S. L. Koh and M. J. Veness, “Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature,” Australasian Journal of Dermatology, vol. 50, no. 4, pp. 249–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. B. Edge and C. C. Compton, “The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1471–1474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. C. Ezeh, J. Bongaarts, and B. Mberu, “Global population trends and policy options,” Lancet, vol. 380, no. 9837, pp. 142–148, 2012. View at Publisher · View at Google Scholar
  47. C. Ulrich, T. Schmook, M. M. Sachse, W. Sterry, and E. Stockfleth, “Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients,” Dermatologic Surgery, vol. 30, no. 4, pp. 622–627, 2004. View at Google Scholar · View at Scopus
  48. A. E. Brissett, K. D. Olsen, J. L. Kasperbauer et al., “Merkel cell carcinoma of the head and neck: a retrospective case series,” Head and Neck, vol. 24, no. 11, pp. 982–988, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. A. L. Dancey, S. S. Rayatt, C. Soon, A. Ilchshyn, I. Brown, and S. Srivastava, “Merkel cell carcinoma: a report of 34 cases and literature review,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 59, no. 12, pp. 1294–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. A. C. Hui, A. L. Stillie, M. Seel, and J. Ainslie, “Merkel cell carcinoma: 27-year experience at the Peter Maccallum cancer centre,” International Journal of Radiation Oncology Biology Physics, vol. 80, no. 5, pp. 1430–1435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. K. C. Wong, F. Zuletta, S. J. Clarke, and P. J. Kennedy, “Clinical management and treatment outcomes of Merkel cell carcinoma,” Australian and New Zealand Journal of Surgery, vol. 68, no. 5, pp. 354–358, 1998. View at Google Scholar · View at Scopus
  52. H. Medina-Franco, M. M. Urist, J. Fiveash, M. J. Heslin, K. I. Bland, and S. W. Beenken, “Multimodality treatment of merkel cell carcinoma: case series and literature review of 1024 cases,” Annals of Surgical Oncology, vol. 8, no. 3, pp. 204–208, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. Gillenwater, A. C. Hessel, W. H. Morrison et al., “Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival,” Archives of Otolaryngology, vol. 127, no. 2, pp. 149–154, 2001. View at Google Scholar · View at Scopus
  54. W. J. O'Connor, R. K. Roenigk, and D. G. Brodland, “Merkel cell carcinoma: comparison of Mohs micrographic surgery and wide excision in eighty-six patients,” Dermatologic Surgery, vol. 23, no. 10, pp. 929–933, 1997. View at Google Scholar · View at Scopus
  55. B. E. Pennington and D. J. Leffell, “Mohs micrographic surgery: established uses and emerging trends,” Oncology, vol. 19, no. 9, pp. 1165–1171, 2005. View at Google Scholar · View at Scopus
  56. P. D. Karkos, A. Sastry, S. Hampal, and M. Al-Jafari, “Spontaneous regression of Merkel cell carcinoma of the nose,” Head and Neck, vol. 32, no. 3, pp. 411–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Ciudad, J. A. Avilés, F. Alfageme, M. Lecona, R. Suárez, and P. Lázaro, “Spontaneous regression in merkel cell carcinoma: report of two cases with a description of dermoscopic features and review of the literature,” Dermatologic Surgery, vol. 36, no. 5, pp. 687–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. J. Hassan, M. Knox, M. Griffin, and M. J. Kennedy, “Spontaneous regression of metastatic merkel cell carcinoma,” Irish Medical Journal, vol. 103, no. 1, pp. 21–22, 2010. View at Google Scholar · View at Scopus
  59. Y. Yagi, A. Fujisawa, M. Makiura, and K. Morita, “Spontaneous regression of Merkel cell carcinoma after biopsy,” Journal of Dermatology, vol. 36, no. 5, pp. 312–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. M. J. Vesely, D. J. Murray, P. C. Neligan et al., “Complete spontaneous regression in Merkel cell carcinoma,” Journal of Plastic, Reconstructive & Aesthetic Surgery, vol. 61, no. 2, pp. 165–171, 2008. View at Publisher · View at Google Scholar
  61. A. G. Richetta, M. Mancini, A. Torroni et al., “Total spontaneous regression of advanced merkel cell carcinoma after biopsy: review and a new case,” Dermatologic Surgery, vol. 34, no. 6, pp. 815–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. G. F. Huber, M. Khalil, V. Falck, T. W. Matthews, and J. C. Dort, “Merkel cell carcinoma with solitary parotid metastasis: diagnostic dilemma in the absence of a primary site,” The Journal of Otolaryngology, vol. 36, no. 5, pp. E70–E72, 2007. View at Google Scholar · View at Scopus
  63. J. L. Deneve, J. L. Messina, S. S. Marzban et al., “Merkel cell carcinoma of unknown primary origin,” Annals of Surgical Oncology, vol. 19, no. 7, pp. 2360–2366, 2012. View at Publisher · View at Google Scholar
  64. T. Inoue, K. Yoneda, M. Manabe, and T. Demitsu, “Spontaneous regression of Merkel cell carcinoma: a comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group,” Journal of Dermatological Science, vol. 24, no. 3, pp. 203–211, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Koba, K. G. Paulson, K. Nagase et al., “Diagnostic biopsy does not commonly induce intratumoral CD8 T cell infiltration in Merkel cell carcinoma,” PloS ONE, vol. 7, no. 7, Article ID e41465, 2012. View at Publisher · View at Google Scholar
  66. T. Jaeger, J. Ring, and C. Andres, “Histological, immunohistological, and clinical features of merkel cell carcinoma in correlation to merkel cell polyomavirus status,” Journal of Skin Cancer, vol. 2012, Article ID 983421, 5 pages, 2012. View at Publisher · View at Google Scholar
  67. M. Heath, N. Jaimes, B. Lemos et al., “Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features,” Journal of the American Academy of Dermatology, vol. 58, no. 3, pp. 375–381, 2008. View at Publisher · View at Google Scholar · View at Scopus